CLINICAL_TRIALS
trial_result
· 2010-02-05
Clinical Trial Update: AZD9668 Relative Bioavailability [Phase 1]
Summary
Phase 1 relative bioavailability study of AZD9668 by AstraZeneca in chronic obstructive pulmonary disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED